VOYAGER THERAPEUTICS, INC revenue for the last year amounted to 4.25 B MXN, the most of which — 4.25 B MXN — came from its highest performing source at the moment, Gene Therapies, the year earlier bringing 797.87 M MXN. The greatest contribution to the revenue figure was made by United States — last year it brought VOYAGER THERAPEUTICS, INC 4.25 B MXN, and the year before that — 797.87 M MXN.